Janssen Fires Back At Amgen's Stelara Patent Suit
Janssen Biotech Inc. has denied claims that a U.K. patent protecting its immunosuppressant Stelara is invalid, in a now-trimmed legal action brought by rival Amgen Inc. targeting patent protections for the...To view the full article, register now.
Already a subscriber? Click here to view full article